Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management (Arundhati Parmar/MedCity News) –

Arundhati Parmar / MedCity News:
Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management  —  The CEO of Anagenex believes that the company’s AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.

Read More